Halozyme.com

Halozyme.com has server used 162.159.135.42 () ping response time Hosted in Cloudflare, Inc. Register Domain Names at GoDaddy.com, LLC. This domain has been created 18 years, 48 days ago, remaining 3 years, 317 days. You can check the 9 Websites and blacklist ip address on this server

Domain information

Registrar WHOIS Server: whois.godaddy.com

Registrar URL: http://www.godaddy.com     See All 2,280,668+

Creation Date: 2003-12-08 18 years, 48 days

Updated Date: 2016-05-29 5 years, 241 days ago

Expiry Date: 2025-12-08 3 years, 317 days left     See All

  Sign up for notifications near expiration

Registrar: GoDaddy.com, LLC

Abuse Email: [email protected]

Abuse Phone: 480-624-2505

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email
www.godaddy.com2,280,668GoDaddy.com, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a PublicDomainRegistry.com[email protected]
www.whois.godaddy.com174,077GoDaddy.com, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions

Halozyme

Halozyme therapeutics

Halozyme stock

Halozyme stock price

Halozyme therapeutics san diego

Halozyme therapeutics stock

Halozyme aktie

Halozyme enhanze

Halozyme investor relations

Halozyme therapeutics news

Halozyme therapeutics aktie

Halozyme therapeutics investor relations

( Please select at least 2 keywords )

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

› Halozyme therapeutics inc news

› Halozyme therapeutics san diego

› Halozyme investor relations

› Halozyme message board

› Halozyme careers

› Halozyme technology

› Halozyme stock

› Halozyme enhanze

Hosting Provider

NetName: CLOUDFLARENET

Organization: Cloudflare, Inc.     See All 637,900+

Provider URL: Cloudflare.com

Hostname: 162.159.135.42

IP Server: 162.159.135.42 Reg: 2013-05-23, Updated: 2021-05-26

Blacklist: Check Backlist Status

Country:

Address: 101 Townsend Street, San Francisco, CA 94107, US

Latitude:

Longitude:

Name Server:

  • NS29.DOMAINCONTROL.COM
  • NS30.DOMAINCONTROL.COM

Abuse Email: [email protected]

Abuse Phone: +1-650-319-8930

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,706GoDaddy.com, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

No Emails Found

Find Websites hosted

1: Bensrvcenter.com

2: Steeleindustries.com

3: Tcoyf.com

4: Sensify.brembo.com

5: Hollandchristian.org

6: Luminafoundation.org

7: Isipkg.com

8: Doyon.com

9: Radiojingles24.com

At least 9 Sites on this server

Port Scanner (IP: 162.159.135.42)

ENHANZE Halozyme

  • Halozyme’s primary technology is based on its proprietary recombinant human hyaluronidase PH20 enzyme (rHuPH20) that degrades hyaluronan, or HA
  • HA is a glycosaminoglycan, a chain of natural sugars that is a component of normal tissue, such as skin and cartilage
  • The effects of rHuPH20 are local and transient.

Halozyme.com   DA: 12 PA: 9 MOZ Rank: 21

Halozyme, Inc. LinkedIn

Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and …

Linkedin.com   DA: 16 PA: 35 MOZ Rank: 52

Shares Halozyme Therapeutics HALO – Quotes, Share Price

  • Halozyme Therapeutics' GAAP net income for 6M 2021 was $119.353 million, up 6.1 times from $19.714 million in the previous year
  • Revenue increased 2.8 times to $225.477 million from $80.575 million a year earlier.

Blackterminal.com   DA: 17 PA: 18 MOZ Rank: 37

Halozyme Therapeutics (HALO) Stock Price, News & Info

  • Price as of January 24, 2022, 4:00 p.m
  • ET View Interactive HALO Charts
  • A biopharmaceutical company dedicated to the …

Fool.com   DA: 12 PA: 19 MOZ Rank: 34

HALOZYME THERAPEUTICS, INC. : HALO Stock Price

  • is a biopharma technology platform company
  • The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine its ENHANZE drug delivery technology with the collaborators' compounds
  • The Company's lead enzyme, rHuPH20, is used to facilitate the delivery of injected

Marketscreener.com   DA: 22 PA: 44 MOZ Rank: 70

Halozyme Therapeutics (HALO) Q3 Earnings And Revenues Top

  • Halozyme Therapeutics (HALO) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.42 per share
  • This compares to earnings of $0.25 per share a year ago.

Markets.businessinsider.com   DA: 27 PA: 50 MOZ Rank: 82

HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND …

  • 10, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc
  • (NASDAQ: HALO) today introduced 2022 financial guidance and commented on its outlook for the upcoming year
  • "Halozyme had another strong year of financial performance in 2021 with record revenues and profitability driven by strong growth of our wave 2 partner products including the …

Biospace.com   DA: 16 PA: 50 MOZ Rank: 72

Halozyme Therapeutics, Inc. (HALO) Stock Price, News

  • Find the latest Halozyme Therapeutics, Inc
  • (HALO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com   DA: 17 PA: 11 MOZ Rank: 35

Current Report Filing (8-k)

  • HALO Halozyme Therapeutics Incorporated Current Report Filing (8-k) On December 13, 2021, Halozyme Therapeutics, Inc
  • (the “Company”) announced that Masaru Matsuda will step down from his position as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary of the Company, effective December 31, 2021, to …

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 70

Enhanced Hyaluronidase-based Drug Delivery

Halozyme has developed ENHANZE, a recombinant human hyaluronidase-based drug delivery technology that enables and optimizes subcutaneous …

Nature.com   DA: 14 PA: 28 MOZ Rank: 51

Halozyme To Present Virtually At The 40th Annual J.P

  • 4, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc
  • (NASDAQ: HALO) today announced that Dr
  • Helen Torley, president and chief executive officer, will present virtually at the 40 th Annual J.P
  • Morgan Health Care Conference on Monday, January 10, 2022 at 7:30 a.m
  • ET.The virtual conference will be held from January 10 …

Biospace.com   DA: 16 PA: 50 MOZ Rank: 76

Halozyme Therapeutics, Inc (HALO) Q2 2021 Earnings Call

  • Halozyme Therapeutics, inc (NASDAQ:HALO) Q2 2021 Earnings Call Aug 9, 2021, 4:30 p.m
  • Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator

Fool.com   DA: 12 PA: 50 MOZ Rank: 73

Halozyme Therapeutics, Inc. (NASDAQ:HALO), Amgen Inc

  • Darzalex Faspro is co-formulated with recombinant human hyaluronidase PH20 (rHuPH20), Halozyme Therapeutics Inc’s (NASDAQ: HALO) Enhanze drug delivery technology
  • “With its three-to-five-minute subcutaneous administration, Darzalex Faspro is now a treatment option for a broader range of patients suffering from multiple myeloma,” said

Billionaireclubcollc.com   DA: 28 PA: 50 MOZ Rank: 90

生物制药公司:奥洛兹美医疗Halozyme Therapeutics(HALO)

奥洛兹美医疗Halozyme Therapeutics, Inc.(NASDAQ:HALO)创立于1998年,总部位于美国加利福尼亚州圣迭戈,全职雇员136人,是一家生物技术公司,致力于研究、开发及商业化和人类蛋白酶。

Mg21.com   DA: 12 PA: 10 MOZ Rank: 35

TD Ameritrade Login

TD Ameritrade Secure Log-In for online stock trading and long term investing clients

Invest.ameritrade.com   DA: 21 PA: 13 MOZ Rank: 48

Halozyme: Good Upside Potential (NASDAQ:HALO) Seeking Alpha

  • Halozyme Therapeutics is a growing company in a growing market
  • The financial performance of HALO is growing at an extremely high rate, and this dynamic is expected to continue until at least 2027.

Seekingalpha.com   DA: 16 PA: 50 MOZ Rank: 81

HALOZYME APPOINTS NEW GENERAL COUNSEL

  • 13, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc
  • (NASDAQ: HALO) today announced that Mark Snyder has been appointed senior vice president, general counsel, chief compliance officer and corporate secretary, effective January 3, 2022.Mr
  • Snyder will succeed Masaru Matsuda, who is stepping down to pursue another opportunity.

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 78

Is Halozyme Therapeutics, Inc. (HALO) A Stock To Watch

  • (HALO) stock is trading at $34.47 as of 11:55 AM on Monday, Dec 13, a loss of -$0.03, or -0.1% from the previous closing price of $34.50
  • So far 349,587 shares have traded compared to average volume of 890,090 shares
  • The stock has traded between $33.52 and $34.63 so far today.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 92

HALOZYME THERAPEUTICS AKTIE News Aktienkurs

  • HALOZYME THERAPEUTICS AKTIE und aktueller Aktienkurs
  • Nachrichten zur Aktie Halozyme Therapeutics Inc

Finanzen.net   DA: 16 PA: 35 MOZ Rank: 69

Will Halozyme Therapeutics, Inc. (HALO) Lag The Rest Of

  • (HALO) stock is trading at $39.47 as of 12:44 PM on Tuesday, Dec 21, a rise of $1.30, or 3.41% from the previous closing price of $38.17
  • The stock has traded between $38.24 and $39.62 so far today

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 94

HALOZYME APPOINTS NEW GENERAL COUNSEL

  • HALOZYME APPOINTS NEW GENERAL COUNSEL
  • 13, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc
  • (NASDAQ: HALO) today announced that Mark Snyder has been appointed senior vice president

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 88

HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK

  • 2022 Financial Guidance: For 2022, Halozyme expects total revenue of $530 million to $560 million, representing growth of 23-26% over 2021 expected total revenue
  • The Company expects revenue from

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 89

Hedge Funds Are Betting On Halozyme Therapeutics, Inc. (HALO)

  • (NASDAQ:HALO) was in 23 hedge funds' portfolios at the end of September
  • The all time high for this statistic is 26
  • The all time high for this statistic is …

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 89

Halozyme Therapeutics (HALO) Stock Message Board

  • Halozyme is a therapeutically driven biopharmaceutical company developing and commercializing recombinant human enzymes to provide enhanced and innovative alternatives that improve the practice of medicine
  • Halozyme is focused on providing life-saving and life-enhancing solutions to the drug delivery, oncology, and dermatology markets.

Investorshub.advfn.com   DA: 22 PA: 33 MOZ Rank: 78

BRIEF-GlaxoSmithKline Says VIIV/Halozyme Sign Exclusive

  • BRIEF-GlaxoSmithKline Says VIIV/Halozyme Sign Exclusive Licensing Agreement
  • June 22 (Reuters) - GlaxoSmithKline PLC: * GLAXOSMITHKLINE PLC - VIIV/HALOZYME SIGN EXCLUSIVE LICENSING AGREEMENT

Reuters.com   DA: 15 PA: 50 MOZ Rank: 89

HALO -- Is Its Stock Price A Worthy Investment

  • Its 4 year price growth rate is now at 155.35%
  • Its 5 year net cashflow from operations growth rate is now at -136.7%
  • The 2 year net income to common stockholders growth rate now stands at -217.15%
  • Over the past 33 months, HALO's revenue has gone up $311,148,000
  • The table below shows HALO's growth in key financial areas

Stocknews.com   DA: 13 PA: 12 MOZ Rank: 50

HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND …

  • 10, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc
  • (NASDAQ: HALO) today introduced 2022 financial guidance and commented on …

Wfmz.com   DA: 12 PA: 50 MOZ Rank: 88

Halozyme Therapeutics, Inc. (HALO) AAII Stock Evaluator

  • is a biopharma technology platform company
  • The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine its ENHANZE drug delivery technology with the collaborators' compounds
  • The Company's lead enzyme, rHuPH20, is used to facilitate the delivery of injected

Aaii.com   DA: 12 PA: 18 MOZ Rank: 57

HALO Halozyme Therapeutics, Inc. Stock Quote

  • operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally
  • The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of

Finviz.com   DA: 10 PA: 11 MOZ Rank: 49

Halozyme Therapeutics Inc.

  • biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships
  • Furthermore, the company was founded in 1998 and went public in 2004
  • Halozyme Migration/Teamwork Case Study.

Klarinetsolutions.com   DA: 25 PA: 39 MOZ Rank: 93

Recently Analyzed

1: 02660266l.com 1 seconds ago

2: Beautywsi.com 4 seconds ago

3: Marketingdata.com 2 seconds ago

4: Linuxrelease.com 0 seconds ago

5: Wegmans.com 1 seconds ago

6: Mineralfusion.com 2 seconds ago

7: Kimdonaldlaw.com 3 seconds ago

8: Firstconguccsandusky.com 5 seconds ago

9: Reptilesofecuador.com 0 seconds ago

10: 92qwe.com 1 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
92qwe.com 73 days leftInternet Domain Service BS CorpSiChuan Century LiXin Financial Management Consulting Co., LTD
Reptilesofecuador.com 269 days leftNameSilo, LLCMicrosoft Corporation
Firstconguccsandusky.com 204 days leftName.com, Inc.Liquid Web, L.L.C
Kimdonaldlaw.com 35 days leftGoDaddy.com, LLCAptum Technologies
Mineralfusion.com4 years, 125 days leftGoDaddy.com, LLCShopify, Inc.
Wegmans.com4 years, 270 days leftNetwork Solutions, LLCFrontier Communications of America, Inc.
Linuxrelease.com 348 days leftNameCheap, Inc.Google LLC
Marketingdata.com 248 days leftKey-Systems GmbHDomain Name Services
Beautywsi.com 156 days leftNameSilo, LLCLinode
02660266l.com 299 days leftGoDaddy.com, LLCDomain Name Services

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]